In the next five years, healthcare and life sciences organizations will be navigating unique, disruptive forces presented by a digital-first world that will shape many aspects of the industry landscape from value-based care to prescription digital therapeutics. A report from IDC Research, a premier global market research company, offers some predictions on how organizations can navigate the winds of change impacting what technologies to adopt, capabilities to advance, and partnerships to pursue.
The findings of the report, IDC FutureScape: Worldwide Healthcare Industry 2022 Predictions, will be highlighted as part of an upcoming webinar sponsored by Twilio. The webinar is scheduled for June 7 at 3:30-4:30pm ET, 12:30-1:30pm PT.
In the discussion between Mutaz Shegewi, IDC Research Director, Dr. Nimita Limaye, IDC Research VP, and Susan Lucas Collins, Global Head of Healthcare Services at Twilio, registrants will learn more about:
- The recent worldwide healthcare industry 2022 predictions moving healthcare and life sciences organizations forward in a digital-first world
- The role innovative and disruptive technologies will play in helping healthcare become more connected and personalized
- Top business and IT considerations for organizations as the industry continues to digitally transform
Twilio is the leading platform for building customer engagement across marketing, services, and operations. With a single programmable platform, marketers can optimize communications across any channel, developers can build differentiated customer experiences, and businesses can grow lasting relationships with their customers. Twilio is headquartered in San Francisco and has offices around the globe.
Here’s a look at the speakers for the webinar:
Susan Lucas Collins, Global Head of Healthcare, Twilio
Susan Collins is a globally recognized expert on healthcare technology and go to market strategy, speaking regularly at conferences and contributing thought leadership to a variety of professional journals and media outlets.
Currently Global Head of Healthcare for Twilio, Collins leads the firm’s healthcare vertical and established Twilio as the leading provider of communications and engagement technology to iconic brands such as Epic, ZocDoc, Doximity, Doctor On Demand and MDLive as well as numerous hospitals & health systems, public health agencies and life sciences organizations.
Previously, she led innovation and healthcare business units at Salesforce, advising the firm’s largest customers on digital transformation and forming partnership agreements with leading health tech firms. She also initiated the category of Enterprise Health Clouds now leveraged by analysts tracking the healthcare CRM space.
Collins has also led organizations within the Yale New Haven and Emory Healthcare systems as Chief Marketing and Client Services Officer for Advanced Radiology and CEO of Atlanta Radiology respectively.
Mutaz Shegewi, Research Director, Provider IT Transformation Strategies, IDC Research
Mutaz Shegewi leads the provider research practice at IDC Health Insights. He covers topics of most relevance to healthcare provider organizations looking to digitally transform and become more digitally native than their competition. Mutaz advises the executive, clinical, and technical leadership of the world’s foremost health information technology supplier and buyer organizations. He produces data-driven research and thought-leadership insights that help to navigate strategic challenges in health information technology and transform complexity to clarity in decision-making that would decrease costs, enhance quality, optimize access, improve patient safety, and champion patient experience. Mutaz is passionate about strengthening healthcare systems through the dynamic interrelations between technology, patients, and providers by combining industry, professional, academic, technical and global expertise in healthcare, policy, business, management, research, consulting, and medicine.
Dr. Nimita Limaye, Research VP, IDC Health Insights
Dr. Nimita Limaye is a Research VP with IDC Health Insights and provides research-based advisory and consulting services, as well as market analysis on key topics related to R&D Strategy and Technology in the life sciences industry. She addresses aspects such as the role of digital transformation in discovery research, e-clinical ecosystems, the role of NLP, AI, ML, DL, RPA, in transforming drug development, precision medicine, pharma R&D execution and strategic outsourcing models.
Nimita is an executive business leader with over two decades of life sciences leadership experience working across the pharma / CRO / life sciences-tech consulting industry. Passionate about the role of data, technology and analytics in transforming clinical trials and paving the way for the trials of the future. She also serves as a mentor for start-ups on the Mass Bio Digital Health initiative.
Nimita has a PhD in Biotechnology and has chaired the board of industry associations such as SCDM. She is actively associated with the DIA and AMWA. She has chaired several conferences, led industry roundtables, given keynote talks, conducted webinars and has authored over 40 publications / white papers. Her primary focus has been on the role of technology in transforming drug development, virtual clinical trials, patient centric clinical trials, the use of social media in drug development, risk-based monitoring, and precision medicine.
Image: elenabs, Getty Images
To register for the June 7 webinar, please fill out the form below.
